Discover a Hidden Junior Silver Mining Leader

Co-Diagnostics, Inc. (Nasdaq: CODX) Leads Nasdaq Top Gainers on new Saudi-based CoMira Diagnostics joint venture

Executives from Co-Diagnostics, Inc. and Arabian Eagle Manufacturing shake hands outside Co-Diagnostics headquarters, with Saudi Arabian and U.S. flags displayed, symbolizing their new CoMira Diagnostics joint venture.

October 27, 2025- (Investorideas.com Newswire), a go-to investing platform covering biotech and medtech stocks releases a news and trading alert for Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests.

The stock makes the Nasdaq top gainers list on news, currently trading at 0.8499 +0.4992, gaining over 142% on volume of over 534 Million shares. Prior to this news , the average volume for the stock was just over 6.5 Million shares.

News summary

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics firm known for its patented Co-Dx™ PCR platform, has entered into a definitive agreement with Arabian Eagle Manufacturing, a Saudi-based company, to launch a joint venture named CoMira Diagnostics. This partnership aims to localize the research, development, manufacturing, assembly, distribution, and commercialization of Co-Dx technologies across the Kingdom of Saudi Arabia (KSA) and 18 other Middle East and North Africa (MENA) countries. The initiative aligns closely with Saudi Vision 2030's priorities of technology localization, industrial diversification, and healthcare innovation, with initial regulatory efforts targeting clearance from the Saudi Food & Drug Administration (SFDA) to streamline market entry throughout the region. 

Co-Diagnostics CEO Dwight Egan highlighted the venture's potential to address growing demand for point-of-care diagnostics in the MENA region, emphasizing the company's commitment to bridging accessibility gaps in high-quality PCR testing. Arabian Eagle CEO Ihssan Rjoob echoed this enthusiasm, noting how the collaboration advances health security and sustainable growth in line with national goals. No specific financial terms were disclosed in the announcement.

Full news

https://finance.yahoo.com/news/co-diagnostics-signs-definitive-agreement-124500232.html


Research biotech and medical device/ tech stocks at Investorideas.com 
https://www.investorideas.com/BIS/


Learn more about our news, PR and social media, podcast services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp

Advertising agencies -Learn more about digital advertising and guest posts at Investorideas
https://www.investorideas.com/Advertise/


About Investorideas.com - Big Investing Ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all

Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Contact Investorideas.com 

800-665-0411




Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. This is not investment opinion: Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services and prices on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp